1ho9: Difference between revisions

← Older edit Newer edit →

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 3: / Line 3: @@
 <StructureSection load='1ho9' size='340' side='right'caption='[[1ho9]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''>
 == Structural highlights ==
-<table><tr><td colspan='2'>[[1ho9]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HO9 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1HO9 FirstGlance]. <br>
+<table><tr><td colspan='2'>[[1ho9]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HO9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1HO9 FirstGlance]. <br>
-</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1hll|1hll]], [[1hof|1hof]], [[1hod|1hod]]</td></tr>
+</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[1hll|1hll]], [[1hof|1hof]], [[1hod|1hod]]</div></td></tr>
-<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1ho9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1ho9 OCA], [http://pdbe.org/1ho9 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=1ho9 RCSB], [http://www.ebi.ac.uk/pdbsum/1ho9 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=1ho9 ProSAT]</span></td></tr>
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1ho9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1ho9 OCA], [https://pdbe.org/1ho9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1ho9 RCSB], [https://www.ebi.ac.uk/pdbsum/1ho9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1ho9 ProSAT]</span></td></tr>
 </table>
 == Function ==
-[[http://www.uniprot.org/uniprot/ADA2A_HUMAN ADA2A_HUMAN]] Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is oxymetazoline > clonidine > epinephrine > norepinephrine > phenylephrine > dopamine > p-synephrine > p-tyramine > serotonin = p-octopamine. For antagonists, the rank order is yohimbine > phentolamine = mianserine > chlorpromazine = spiperone = prazosin > propanolol > alprenolol = pindolol.<ref>PMID:23105096</ref>
+[[https://www.uniprot.org/uniprot/ADA2A_HUMAN ADA2A_HUMAN]] Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is oxymetazoline > clonidine > epinephrine > norepinephrine > phenylephrine > dopamine > p-synephrine > p-tyramine > serotonin = p-octopamine. For antagonists, the rank order is yohimbine > phentolamine = mianserine > chlorpromazine = spiperone = prazosin > propanolol > alprenolol = pindolol.<ref>PMID:23105096</ref>
 == Evolutionary Conservation ==
 [[Image:Consurf_key_small.gif|200px|right]]